Nurix (NRIX) PT Lowered to $34 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Nurix (NRIX) PT Lowered to $16 at Morgan Stanley
July 14, 2025 10:11 AM EDTMorgan Stanley analyst Terence Flynn lowered the price target on Nurix (NASDAQ: NRIX) to $16.00 (from $17.00) while maintaining a Equalweight rating.
The analyst comments "Pipeline on track with clinical updates expected in 2H25. Bexobrutideg (NX-5948) remains the key driver for the stock, with NRIX... More
